Oral mucosal diseases are common health problems that reduce overall wellbeing and increase the risk for several systemic diseases. Due to the limitations of present diagnostics, new non-invasive methods are needed for reliable, affordable, real-time screening and follow-up of oral mucosal lesions. Bioimpedance spectroscopy, spectral camera imaging and other optical methods are promising novel techniques to detect abnormal changes in oral mucosa. In this review, the current status of bioimpedance spectroscopy and autofluorescence utilising spectral camera techniques in the assessment of oral mucosal health is critically evaluated. Scientific publications related to bioimpedance spectroscopy were surveyed using PubMed and Scopus databases. Search was done using a combination of terms "oral mucosa", "oral cancer", "squamous cell cancer", "tissue", "electrical impedance measurement" and "bioimpedance spectroscopy". Publications related to spectral cameras were searched from PubMed with a focus on autofluorescence utilising spectral camera techniques. Search was done using terms "autofluorescence", "oral disease" and "VELscope" publication date restricted from 2008 to date. In this review, we also discuss the future trends and strategies such as combining different methods, e.g. spectral cameras and bioimpedance spectroscopy that could represent a unique multimodality in vivo tool for providing complementary information on the health status of the oral mucosa.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/03091902.2019.1692940 | DOI Listing |
Bioelectromagnetics
January 2025
Micropropulsion and Nanotechnology Laboratory, School of Engineering and Applied Science, George Washington University, Washington, DC, USA.
Cancer remains a formidable global health challenge, necessitating the development of innovative diagnostic techniques capable of early detection and differentiation of tumor/cancerous cells from their healthy counterparts. This review focuses on the confluence of advanced computational algorithms with noninvasive, label-free impedance-based biophysical methodologies-techniques that assess biological processes directly without the need for external markers or dyes. This review elucidates a diverse array of state-of-the-art impedance-based technologies, illuminating distinct electrical signatures inherent to cancer vs healthy tissues.
View Article and Find Full Text PDFBiomimetics (Basel)
January 2025
School of Mechanical Engineering, Jiangsu University of Technology, Changzhou 213001, China.
To reduce hip joint muscles' activation during walking with an active hip exoskeleton. Few studies examine the optimal active assistance timing of the hip exoskeleton based on muscle activation characteristics. Sixteen gender-balanced healthy adults (mean age 28.
View Article and Find Full Text PDFMed Sci Sports Exerc
January 2025
Kinesiology & Health Science, Utah State University, Logan, UT.
Purpose: This study compared %BFUS to %BF4C in young adult athletes.
Methods: University club sport athletes (86 women, 138 men) from a variety of teams participated. ADP, DXA, and bioimpedance spectroscopy were used to measure body volume, bone mineral content, and total body water, respectively, for the 4C model.
Diagnostics (Basel)
December 2024
Department of Nephrology, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.
: Hemodialysis patients face a high mortality risk, requiring effective clinical assessments. In these patients, muscle wasting due to protein-energy wasting (PEW) leads to increased frailty, which is strongly associated with worse outcomes, including higher mortality. As muscle mass declines, so does functional capacity, making regular assessment of both muscle mass and function critical for prognostic evaluation.
View Article and Find Full Text PDFProg Biomed Eng (Bristol)
January 2025
Amrita Vishwa Vidyapeetham, Center for Wireless Networks & Applications (WNA), Amrita Vishwa Vidyapeetham Amritapuri, Kollam, India, Kollam, 690525, INDIA.
Lymphedema is localized swelling due to lymphatic system dysfunction, often affecting arms and legs due to fluid accumulation. It occurs in 20% to 94% of patients within 2 to 5 years after breast cancer treatment, with around 20% of women developing breast cancer-related lymphedema (BCRL). This condition involves the accumulation of protein-rich fluid in interstitial spaces, leading to symptoms like swelling, pain, and reduced mobility that significantly impact quality of life.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!